Parasitic Diseases
Parasitic Diseases(寄生虫病)
Parasitic Diseases 相关产品(169)
- GC49773Albendazole sulfone-d3CAS: 1448345-60-5纯度: >99.00%
An internal standard for the quantification of albendazole sulfone
- GC49837Gypsogenic AcidCAS: 5143-05-5纯度: >95.00%
A triterpene acid with antibacterial and trypanocidal activities
- GC49852Clindamycin (hydrochloride hydrate)CAS: 58207-19-5纯度: >98.00%
Clindamycin (hydrochloride hydrate)是一种林可酰胺类抗生素,用于治疗由敏感厌氧菌、链球菌、葡萄球菌和肺炎球菌引起的严重感染,主要用于骨髓炎、呼吸系统感染、胆道感染、心内膜炎、中耳炎、皮肤软组织感染及败血症等。
- GC52040Ipronidazole-d3CAS: 1015855-83-0纯度: >99.00%
An internal standard for the quantification of ipronidazole
- GC52072Febrifugine (hydrochloride)CAS: 32434-42-7纯度: >98.00%
A quinazolinone with antimalarial activity
- GC52171Clindamycin-d3 (hydrochloride)CAS: 1356933-72-6纯度: >99.00%
An internal standard for the quantification of clindamycin
- GC52174Sulfadoxin-d4CAS: 1330266-05-1纯度: >99.00%
An internal standard for the quantification of sulfadoxin
- GC52434Marbofloxacin-d8 (hydrochloride)纯度: >99.00%
An internal standard for the quantification of marbofloxacin
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC49551 | 6-Chloropurine Riboside | 5399-87-1 | >98.00% | |
A nucleoside precursor | ||||
| GC49661 | Miltefosine-d4 | - | >99.00% | |
An internal standard for the quantification of miltefosine | ||||
| GC49773 | Albendazole sulfone-d3 | 1448345-60-5 | >99.00% | |
An internal standard for the quantification of albendazole sulfone | ||||
| GC49774 | Ipronidazole | 14885-29-1 | >90.00% | |
A nitroimidazole antiprotozoal agent | ||||
| GC49786 | 2-NP-AOZ | 19687-73-1 | >95.00% | |
A derivatized metabolite of furazolidone | ||||
| GC49804 | Acridine | 260-94-6 | >98.00% | |
An azaarene | ||||
| GC49832 | Hydroxymetronidazole | 4812-40-2 | >95.00% | |
An active metabolite of metronidazole | ||||
| GC49837 | Gypsogenic Acid | 5143-05-5 | >95.00% | |
A triterpene acid with antibacterial and trypanocidal activities | ||||
| GC49852 | Clindamycin (hydrochloride hydrate) | 58207-19-5 | >98.00% | |
Clindamycin (hydrochloride hydrate)是一种林可酰胺类抗生素,用于治疗由敏感厌氧菌、链球菌、葡萄球菌和肺炎球菌引起的严重感染,主要用于骨髓炎、呼吸系统感染、胆道感染、心内膜炎、中耳炎、皮肤软组织感染及败血症等。 | ||||
| GC52007 | N-hydroxylamine Dapsone | 32695-27-5 | >98.00% | |
An active metabolite of dapsone | ||||
| GC52029 | 2-Aminoflubendazole | 82050-13-3 | >95.00% | |
A metabolite of flubendazole | ||||
| GC52040 | Ipronidazole-d3 | 1015855-83-0 | >99.00% | |
An internal standard for the quantification of ipronidazole | ||||
| GC52072 | Febrifugine (hydrochloride) | 32434-42-7 | >98.00% | |
A quinazolinone with antimalarial activity | ||||
| GC52082 | Dimidium (bromide) | 518-67-2 | >98.00% | |
A trypanocide | ||||
| GC52171 | Clindamycin-d3 (hydrochloride) | 1356933-72-6 | >99.00% | |
An internal standard for the quantification of clindamycin | ||||
| GC52174 | Sulfadoxin-d4 | 1330266-05-1 | >99.00% | |
An internal standard for the quantification of sulfadoxin | ||||
| GC52191 | Deacetylanisomycin | 27958-06-1 | >95.00% | |
A derivative of anisomycin | ||||
| GC52403 | Ivermectin-d2 | - | >99.00% | |
An internal standard for the quantification of ivermectin | ||||
| GC52434 | Marbofloxacin-d8 (hydrochloride) | - | >99.00% | |
An internal standard for the quantification of marbofloxacin | ||||
| GC91135 | 4-(3,4-Difluorobenzo)curcumin | 1170354-22-9 | >95.00% | |
一种半合成的香豆素,具有抗寄生虫和抗癌活性。 | ||||
| GC91141 | DXR Inhibitor 11a (sodium salt) | - | >98.00% | |
一种抑制 P. falciparum DXR的物质。 | ||||
| GC91170 | NPD-2975 | 3032452-65-3 | >98.00% | |
一种抗寄生虫药物 | ||||
| GC91181 | Malathion-d10 | 347841-48-9 | >99.00% | |
一种用于量化马拉硫磷的内部标准 | ||||
| GC91229 | DXR Inhibitor 11a (free acid) | 2260608-07-7 | >98.00% | |
一种抑制 P. falciparum DXR的药物。 | ||||
